Pricing

VIVO CAPITAL, LLC

3 followers ยท
PALO ALTO CA Investment Advisor Hedge Fund
13F Summary

Subscription Required

Equal-WT
WhaleScore 2.0 ?

85

S&P 500
WhaleScore ?

Subscription Required

Equal-WT
WhaleScore 1.0 ?

Vivo Capital is based out of Palo Alto. Their last reported 13F filing for Q2 2024 included $1,082,541,398 in managed 13F securities and a top 10 holdings concentration of 76.04%. Vivo Capital's largest holding is Soleno Therapeutics Inc with shares held of 7,316,851. Whalewisdom has at least 37 13F filings, and 3 13D filings

2024-06-30

Top Buys (13F)

Name % Change
ERAS Erasca Inc 1.47%
CELC Celcuity Inc 0.92%
ABEOW ABEONA THERAPEUTICS 0.72%
CRBP Corbus Pharmaceutica 0.7%
TIL Instil Bio Inc 0.06%

2024-06-30

Top Sells (13F)

2024-06-30

13F Holdings Summary

Name $ Change
SLNO Soleno Therapeutics 27.58%
GERN Geron Corp 10.66%
HRMY Harmony Biosciences 7.26%
SVA Sinovac Biotech Ltd 7.05%
DYN Dyne Therapeutics, I 5.33%

2024-06-30

13F Activity

Market Value $1.08b, Prior: $1.27b
Inflows (Outflows) as % of Total MV (-5.6763)%
New Purchases 4 stocks
Added To 2 stocks
Sold out of 4 stocks
Reduced holdings in 6 stocks
Top 10 Holdings % 76.04%
Turnover %[1] 17.39%
Turnover Alt %[2] 4.09%
Time Held Top 20 5.4 quarters
Time Held Top 10 4.7 quarters
Time Held All 10.24 quarters

[1]: Turnover is calculated by taking the # of new holdings (initial purchases) + the # of positions sold out of (not just reduced) divided by the total # of holdings for the quarter.

[2]: Alt Turnover is calculated by taking either the total MV of new purchases or the MV of securities sold, whichever is less, divided by the total MV of the fund.

2024-06-30

13F Sector Allocation Over Time

limited to past 4 quarters. Subscribe to see all available data

2024-06-30

Analysis

Top 20 equal-weighted holdings. Performance numbers calculated through 2024-06-30

Portfolio Performance